Publications by authors named "Laise Vilasboas Schettini"
Article Synopsis
- Sickle cell disease (SCD) is a major public health concern in Bahia, Brazil, with erythrocyte transfusions commonly used to alleviate symptoms, though they carry risks like alloimmunization.
- A study examined 108 adult SCD patients who had received multiple transfusions, revealing that 56 developed alloantibodies, primarily against anti-E, anti-K, and anti-C antigens.
- Despite differences in demographics and lab test results, there were no significant variations in clinical complications like leg ulcers or strokes between patients with and without alloantibodies.
